News

1. Creative Biolabs Targets Key Barriers in Lipid-Based Delivery

   Creative Biolabs expands functionalized lipid-based delivery system development capabilities, helping researchers address persistent challenges in targeting, carrier stability, biological responsiveness, and controlled payload release.

2. Health Canada Clears Updated Clinical Trial Protocol for Redsenol-1 Plus

   Clinical Trial Update on Redsenol-1 Plus for Cancer-Related Fatigue Research

3. Creative Biolabs Expands Advanced Single-Cell Multi-Omics and RNA Sequencing Solutions to Support Biomedical Discovery

   Creative Biolabs has expanded its single-cell analysis capabilities to support increasingly complex biomedical research applications.

4. Veedma Launches Free Doctor-Reviewed Lab Analysis for Men's Hormone Health

   Men can turn recent lab results into a personalized clinical report from a licensed doctor and understand the cause before considering treatment.

5. DM Clinical Research Marks 20 Years of Advancing Clinical Research

   20 Years of Impact: Expanding Patient Access and Accelerating Innovation

6. Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Accelerate Next-Generation POCT Diagnostics

   Creative Biolabs has expanded its development platform by integrating advanced chip-based fluidics with electronic detection architectures.

7. The Power of Evidence-Led Strategy: Stelios Tzellos, PhD, on Why Scientific Thinking Should Drive Oncology Market Planning

   Stelios Tzellos explains why scientific understanding, not data alone, leads to more accurate pharmaceutical strategy.

8. Next-Generation Precision Obesity Models: Closing the Translational Gap in Anti-Obesity Drug Development

   Moving Beyond the Scale—How Precision-Engineered Models Are Redefining Preclinical Obesity Research

9. Creative Enzymes Launches AI-Integrated Biocatalysis Platform to Accelerate Enzyme Development

   AI-Powered Biocatalysis: Closing the Gap Between Discovery and Industrial Scale

10. Amerigo Scientific Releases High-Quality iPSC-Derived Cells to Accelerate Biomedical Research and Cell Therapy Development

    Amerigo Scientific recently released high-purity, premium-quality induced pluripotent stem cell (iPSC)-derived cells and engineered reporter iPSC-derived cells.